Table 1.

Demographic and clinical characteristics of the study population (exploratory cohort)

	PD n = 138	HD n = 537	p
Age (years)	51 ± 15	53 ± 13	0.093
Gender (% male)	75%	68%	0.626
Dialysis duration (months)	33 + 20	63 + 123	0.168
Diabetes (%)	19%	20%	0.775
BMI	25.8 ± 4.9	25.8 ± 4.8	0.988
Pre-transplant CMV exposure	55%	54%	0.822
Induction therapy (% of patients having received ATG)	33%	36%	0.567
Tacrolimus (%)	62%	58%	0.348
MMF (%)	97%	97%	0.960
Scheduled stéroids withdrawal (%)	8%	9%	0.720